Balchem Corp (BCPC)

Add to Watchlists
Create an Alert
Quickflows
98.53 +3.25  +3.41% NASDAQ Mar 30, 15:35 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All BCPC News

News

View All Events

Events

Date Type Description
05/01/2020 11:00 EDT Misc Balchem Corp First Quarter Earnings Conference Call in 2020
05/01/2020 Earnings Balchem Corp First Quarter Earnings in 2020 Release
02/21/2020 11:00 EST Misc Balchem Corp Fourth Quarter Earnings Conference Call for 2019
02/21/2020 Earnings Balchem Corp Fourth Quarter Earnings in 2019 Release
02/21/2020 Misc Balchem Corp Annual Report for 2019
12/27/2019 Dividends Amount: 0.52, Declared Date: Dec 18 2019, Pay Date: Jan 17 2020
11/05/2019 11:00 EST Misc Balchem Corp Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings Balchem Corp Third Quarter Earnings in 2019 Release
08/01/2019 11:00 EDT Misc Balchem Corp Second Quarter Earnings Conference Call in 2019
08/01/2019 Earnings Balchem Corp Second Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 643.70M
Total Expenses (TTM) 541.15M
Net Income (TTM) 79.67M

Balance Sheet View Statement

Total Assets (Quarterly) 1.156B
Total Liabilities (Quarterly) 412.02M
Shareholders Equity (Quarterly) 743.67M

Cash Flow Statement View Statement

Cash from Operations (TTM) 124.46M
Cash from Investing (TTM) -156.22M
Cash from Financing (TTM) 43.38M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.balchem.com
  • Investor Relations URL: http://balchem.com/investor-relations
  • HQ State/Province: New York
  • Sector: Basic Materials
  • Industry: Specialty Chemicals
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: May. 01, 2020
  • Last Earnings Release: Feb. 21, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 27, 2019
  • Description: Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and industrial applications. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 98.53
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
BCSIX Brown Capital Mgmt Small Co Inv 3.55%
WIGRX Wasatch Core Growth Institutional 2.92%
CCASX Conestoga Small Cap Investors 2.12%
NWKBX Nationwide Geneva Small Cap Gr C 1.81%
SMDV ProShares Russell 2000 Dividend Growers 1.65%
SLYG SPDR® S&P 600 Small Cap Growth ETF 1.09%
IJT iShares S&P Small-Cap 600 Growth ETF 1.07%
SPSM SPDR® Portfolio S&P 600 Sm Cap ETF 0.60%
IJR iShares Core S&P Small-Cap ETF 0.59%
CSPYX Columbia Small Cap Index Inst3 0.46%
VIOO Vanguard S&P Small-Cap 600 ETF 0.44%
VTSIX Vanguard Tax-Managed Small Cap I 0.42%

Comparables

Edit
ALB Albemarle Corp
DD DuPont de Nemours Inc
ESI Element Solutions Inc
HUN Huntsman Corp
IOSP Innospec Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.